AI assistant
Sending…
IGC Pharma, Inc. — Director's Dealing 2021
May 14, 2021
34705_dirs_2021-05-14_016a2fcf-0572-46f6-bf19-910bdca26e3f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: India Globalization Capital, Inc. (IGC)
CIK: 0001326205
Period of Report: 2021-05-13
Reporting Person: MUKUNDA RAM (Director, CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-05-13 | COMMON STOCK | A | 1000000 | $0.00 | Acquired | 3774760 | Direct |
| 2021-05-13 | COMMON STOCK | A | 50000 | $0.00 | Acquired | 777417 | Indirect |
Footnotes
F1: Represents restricted shares of common stock subject to vesting over three years.
More from IGC Pharma, Inc.
Capital/Financing Update
2026
Jun 8
Interim / Quarterly Report
2026
May 15
Capital/Financing Update
2026
Apr 20
Regulatory Filings
2026
Mar 30
Annual Report
2026
Mar 18
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Jan 20
Capital/Financing Update
2026
Jan 6
Regulatory Filings
2026
Jan 2
Capital/Financing Update
2025
Dec 15